Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition
Go back to Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 62.32 +0.91 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.41 | 52 Week High | $3.48 | |||
| Open | $61.81 | 52 Week Low | $0.80 | |||
| Day High | $62.58 | P/E | N/A | |||
| Day Low | $61.61 | EPS | $-1.54 | |||
| Volume | 2,629,291 | |||||
